Showing results (511-520 of 569) with videos related to

Sort By:
Pageof 57
Plos One|May 22, 2014
Genome-wide identification of expression quantitative trait loci (eQTLs) in human heartTamara T Koopmann, Michiel E Adriaens, Perry D Moerland, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2025
Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?Martha C Faraguna, Daniël A M Lambregts, Ina Barzel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2019
AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcomaBas Vaarwerk, Marinka L F Hol, Reineke A Schoot, et al.
Gastrointestinal Endoscopy|December 18, 2024
Improvement in obesity-related comorbidities 5 years after endoscopic sleeve gastroplasty: a prospective cohort studyAli Lahooti, Donevan Westerveld, Kate Johnson, et al.
Journal of Autism and Developmental Disorders|March 25, 2022
Spoken Language Change in Children on the Autism Spectrum Receiving Community-Based InterventionsDavid Trembath, Matt Stainer, Teena Caithness, et al.
European Journal of Human Genetics : EJHG|November 9, 2020
Enzymatic diagnosis of Pompe disease: lessons from 28 years of experienceMonica Y Niño, Mark Wijgerde, Douglas Oliveira Soares de Faria, et al.
Human Mutation|December 14, 2011
Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complexMarianne Hoogeveen-Westerveld, Rosemary Ekong, Sue Povey, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 1, 2016
Pompe disease in adulthood: effects of antibody formation on enzyme replacement therapyJuna M de Vries, Esther Kuperus, Marianne Hoogeveen-Westerveld, et al.
Gynecologic Oncology|August 7, 2018
Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trialB G Wortman, T Bosse, R A Nout, et al.
Scandinavian Journal of Gastroenterology|June 18, 2019
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patientsDirk P van Asseldonk, Melek Simsek, Nanne K H de Boer, et al.
Pageof 57